Literature DB >> 31063584

Activation of peroxisome proliferator-activated receptor delta suppresses BACE1 expression by up-regulating SOCS1 in a JAK2/STAT1-dependent manner.

Won Jin Lee1, Sun Ah Ham1, Gyeong Hee Lee1, Mi-Jung Choi1, Hyunjin Yoo2, Kyung Shin Paek3, Dae-Seog Lim4, Kwonho Hong2, Jung Seok Hwang1, Han Geuk Seo1.   

Abstract

Neuronal expression of beta-secretase 1 (BACE1) has been implicated in the progression of Alzheimer's disease. However, the mechanisms that regulate BACE1 expression are unclear. Here, we show that peroxisome proliferator-activated receptor delta (PPARδ) decreases BACE1 expression by up-regulating suppressor of cytokine signaling 1 (SOCS1) in SH-SY5Y neuroblastoma cells. The activation of PPARδ by GW501516, a specific PPARδ agonist, inhibited expression of BACE1. This effect was abrogated by shRNA-mediated knockdown of PPARδ and by treatment with the PPARδ antagonist GSK0660, indicating that PPARδ is involved in GW501516-mediated suppression of BACE1 expression. On the other hand, GW501516-activated PPARδ induced expression of SOCS1, which is a negative regulator of cytokine signal transduction, at the transcriptional level by binding to a PPAR response element in its promoter. This GW501516-mediated induction of SOCS1 expression led to down-regulation of BACE1 expression via inactivation of signal transducer and activator of transcription 1. GW501516-activated PPARδ suppressed the generation of neurotoxic amyloid beta (Aβ) in accordance with the decrease in BACE1 expression. Taken together, these results indicate that PPARδ attenuates BACE1 expression via SOCS1-mediated inhibition of signal transducer and activator of transcription 1 signaling, thereby suppressing BACE1-associated generation of neurotoxic Aβ.
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; BACE1; PPARδ; SOCS1; STAT1; amyloid beta

Mesh:

Substances:

Year:  2019        PMID: 31063584     DOI: 10.1111/jnc.14715

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Single-cell peripheral immunoprofiling of Alzheimer's and Parkinson's diseases.

Authors:  Thanaphong Phongpreecha; Rosemary Fernandez; Dunja Mrdjen; Anthony Culos; Chandresh R Gajera; Adam M Wawro; Natalie Stanley; Brice Gaudilliere; Kathleen L Poston; Nima Aghaeepour; Thomas J Montine
Journal:  Sci Adv       Date:  2020-11-25       Impact factor: 14.136

2.  Whole Blood Expression Pattern of Inflammation and Redox Genes in Mild Alzheimer's Disease.

Authors:  Elena Milanesi; Maria Dobre; Cătălina Anca Cucos; Ana I Rojo; José Jiménez-Villegas; Estibaliz Capetillo-Zarate; Carlos Matute; Gerard Piñol-Ripoll; Gina Manda; Antonio Cuadrado
Journal:  J Inflamm Res       Date:  2021-11-20

Review 3.  Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases.

Authors:  Doo Sin Jo; Na Yeon Park; Dong-Hyung Cho
Journal:  Exp Mol Med       Date:  2020-09-11       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.